AU2002247690A1 - Transdermal therapeutic system containing testosterone and method for the production thereof - Google Patents

Transdermal therapeutic system containing testosterone and method for the production thereof

Info

Publication number
AU2002247690A1
AU2002247690A1 AU2002247690A AU2002247690A AU2002247690A1 AU 2002247690 A1 AU2002247690 A1 AU 2002247690A1 AU 2002247690 A AU2002247690 A AU 2002247690A AU 2002247690 A AU2002247690 A AU 2002247690A AU 2002247690 A1 AU2002247690 A1 AU 2002247690A1
Authority
AU
Australia
Prior art keywords
production
system containing
therapeutic system
transdermal therapeutic
containing testosterone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002247690A
Other versions
AU2002247690B2 (en
Inventor
Frank Theobald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10107663A external-priority patent/DE10107663B4/en
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU2002247690A1 publication Critical patent/AU2002247690A1/en
Application granted granted Critical
Publication of AU2002247690B2 publication Critical patent/AU2002247690B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002247690A 2001-02-19 2002-02-07 Transdermal therapeutic system containing testosterone and method for the production thereof Ceased AU2002247690B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10107663.0 2001-02-19
DE10107663A DE10107663B4 (en) 2001-02-19 2001-02-19 Testosterone-containing transdermal therapeutic system, process for its preparation and its use
PCT/EP2002/001258 WO2002066018A2 (en) 2001-02-19 2002-02-07 Transdermal therapeutic system containing testosterone and method for the production thereof

Publications (2)

Publication Number Publication Date
AU2002247690A1 true AU2002247690A1 (en) 2003-02-27
AU2002247690B2 AU2002247690B2 (en) 2006-06-22

Family

ID=7674535

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002247690A Ceased AU2002247690B2 (en) 2001-02-19 2002-02-07 Transdermal therapeutic system containing testosterone and method for the production thereof

Country Status (12)

Country Link
US (1) US20040120994A1 (en)
EP (1) EP1361869B1 (en)
JP (1) JP4851683B2 (en)
KR (1) KR100787545B1 (en)
CN (1) CN100349571C (en)
AR (1) AR033861A1 (en)
AT (1) ATE522205T1 (en)
AU (1) AU2002247690B2 (en)
CA (1) CA2438657C (en)
DE (1) DE10107663B4 (en)
ES (1) ES2368830T3 (en)
WO (1) WO2002066018A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
JO2492B1 (en) 2003-04-28 2009-10-05 شيرينج ايه جي pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
US7850987B2 (en) * 2004-04-08 2010-12-14 Micronutrient, Llc Nutrient composition(s) and system(s) for individualized, responsive dosing regimens
DE102006026060B4 (en) * 2006-01-12 2013-01-31 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing as active ingredient nicotine and method for producing such systems
KR100871531B1 (en) * 2007-01-16 2008-12-05 익수제약 주식회사 Topical preparation of testosterone
JP5338030B2 (en) * 2007-01-31 2013-11-13 大正製薬株式会社 Adapalene-containing external preparation composition
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
WO2011112709A1 (en) * 2010-03-09 2011-09-15 Elan Pharma International Limited Alcohol resistant enteric pharmaceutical compositions
JO3755B1 (en) * 2011-01-26 2021-01-31 Ferring Bv Testosterone formulations
US20160228456A1 (en) * 2013-10-01 2016-08-11 Novartis Ag Combination
US11160753B2 (en) 2015-03-02 2021-11-02 Medlab Clinical U.S., Inc. Transmucosal and transdermal delivery systems
JP7008191B2 (en) * 2017-07-07 2022-02-10 パナソニックＩｐマネジメント株式会社 Information provision method, information processing system, information terminal, and information processing method
CN110537094B (en) * 2017-07-07 2022-03-08 松下知识产权经营株式会社 Information providing method, information processing system, information terminal, and information processing method
CN110537096B (en) * 2017-07-07 2022-03-08 松下知识产权经营株式会社 Information providing method, information processing system, information terminal, and information processing method
US20200330371A1 (en) 2017-10-30 2020-10-22 Teikoku Seiyaku Co., Ltd. Transdermally administrable preparation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
DE3836862A1 (en) * 1988-10-27 1990-05-03 Schering Ag Composition for the transdermal administration of steroid hormones
WO1990004397A1 (en) * 1988-10-27 1990-05-03 Schering Aktiengesellschaft Berlin Und Bergkamen Preparation for transdermal application containing gestodene
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
US5164190A (en) * 1990-12-11 1992-11-17 Theratech, Inc. Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
JPH04261119A (en) * 1991-02-13 1992-09-17 Lintec Corp Percutaneous absorption-type pharmaceutical preparation
DE4210165A1 (en) * 1991-07-30 1993-02-04 Schering Ag TRANSDERMAL THERAPEUTIC SYSTEMS
EP0581587A3 (en) * 1992-07-31 1995-05-17 Tanabe Seiyaku Co Base for transdermal administration.
US5635466A (en) * 1992-08-21 1997-06-03 The Procter & Gamble Company Concentrated liquid detergent composition comprising an alkyl ether sulphate and a process for making the composition
DE4310012A1 (en) * 1993-03-27 1994-09-29 Roehm Gmbh Dermal therapeutic system made of a meltable poly (meth) acrylate mixture
JP3576608B2 (en) * 1994-11-15 2004-10-13 日東電工株式会社 Patches and patch preparations
FR2732223B1 (en) * 1995-03-30 1997-06-13 Sanofi Sa PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL ADMINISTRATION
DE19701949A1 (en) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermal therapeutic system
KR100215027B1 (en) * 1997-01-27 1999-08-16 성재갑 Composition for transdermal administration of steroid drugs and formulation containing same
AU1728099A (en) * 1997-12-22 1999-07-12 Alza Corporation Monoglyceride and ethyl palmitate permeation enhancer compositions
GB9800526D0 (en) * 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
DE19918106A1 (en) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermal patches containing basic or neutral drug include adhesive (meth)acrylic acid polymer in alkali(ne earth) metal salt form
DE10019171A1 (en) * 2000-04-07 2001-10-18 Schering Ag Compositions for use as penetration enhancers in transdermal formulations for highly lipophilic active ingredients
KR100403051B1 (en) * 2000-07-25 2003-10-23 일양약품주식회사 Composition of matrix type patch for transdermal testosterone delivery and process for preparing the same

Similar Documents

Publication Publication Date Title
AU2002345612A1 (en) Ultrasound-fluoroscopic seed therapy system and method
AU2003282580A1 (en) Contrast therapy system and method
AU2002348135A1 (en) Methods for the treatment of addiction
AU2002350109A1 (en) Methods and apparatus for cryo-therapy
AU2002307768A1 (en) System and method for phytomonitoring
AU2002303283A1 (en) Methods for treating drug addiction
AU2002232465A1 (en) Modified methods and apparatus for tcp
AU2003285491A1 (en) Electropolishing system and process
AU2002250858A1 (en) Capsule-in-capsule system and method for the production thereof
AU2001245288A1 (en) Overhanging form system and method of using the same
AU2002247690A1 (en) Transdermal therapeutic system containing testosterone and method for the production thereof
IL163845A0 (en) Method and system for the automaticplanning of experiments
AU2003260984A1 (en) S-(-)-amlodipine nicotinate and process for the preparation thereof
AU7750100A (en) Method for the treatment of obesity
AU5057600A (en) Component and method for the production thereof
AU2002359061A1 (en) Surface treatment system and method thereof
AU4751300A (en) Method and device for the continuous production of NaAlCl4 or NaFeCl4
AUPQ583100A0 (en) Fastening apparatus and methods for their production and use
AU1734801A (en) Processes for producing tetrahydropyranyl-4-sulfonate and 4-aminotetrahydropyrancompound
AU5174699A (en) Apparatus and method for the production of disinfectant
AU2002332626A1 (en) Method and apparatus using idstm for multi-agent therapy
AU4957100A (en) Method and device for the manufacture of composite products
AU2002342493A1 (en) Angular decoration-holding device and method for the production thereof
AU2417701A (en) Method and apparatus for the manufacture of glued structures
AU2002216364A1 (en) Novel substance fki-1083 and process for producing the same